An enzyme-linked immunosorbent assay for host cell protein contaminants in recombinant PEGylated staphylokinase mutant SY161. (Q40728398)

23 September 2017

An enzyme-linked immunosorbent assay for host cell protein contaminants in recombinant PEGylated staphylokinase mutant SY161. (English)

1 reference

23 September 2017

1 reference

Min Wan

1

1 reference

23 September 2017

Yunjuan Wang

2

1 reference

23 September 2017

Susan Rabideau

3

1 reference

23 September 2017

Randall Moreadith

4

1 reference

23 September 2017

Jeff Schrimsher

5

1 reference

23 September 2017

Greg Conn

6

1 reference

23 September 2017

1 June 2002

1 reference

23 September 2017

11

1 reference

Journal of Pharmaceutical and Biomedical Analysis

inferred from page(s)

published in

1 reference

23 September 2017

28

1 reference

23 September 2017

5

1 reference

23 September 2017

953-963

1 reference

Quantitation of residual Escherichia coli DNA in recombinant biopharmaceutical proteins by hybridization analysis.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Sensitive quantitation of endotoxin by enzyme-linked immunosorbent assay with monoclonal antibody against Limulus peptide C

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Protein purification: aspects of processes for pharmaceutical products

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Quantitation of E. coli protein impurities in recombinant human interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

An immunoligand assay for quantitation of process specific Escherichia coli host cell contaminant proteins in a recombinant bovine somatotropin.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

A non-isotopic probe-hybridization assay for residual DNA in biopharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Immunization procedures for E. coli proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Host cell contaminant protein assay development for recombinant biopharmaceuticals.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Detection of host-derived contaminants in products of recombinant DNA technology in E. coli: a comparison of silver-staining and immunoblotting

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Enzyme-linked immunosorbent assays (ELISAs) for the determination of contaminants resulting from the immunoaffinity purification of recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Immunoassay for the detection of E. coli proteins in recombinant DNA derived human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Recombinant staphylokinase variants with altered immunoreactivity. II: Thrombolytic properties and antibody induction

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Recombinant staphylokinase variants with altered immunoreactivity. I: Construction and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900712-9

7 January 2021

10.1016/S0731-7085(01)00712-9

Identifiers

DOI

1 reference

23 September 2017

1 reference